GammaTile and Stupp in Newly Diagnosed GBM
Public ClinicalTrials.gov record NCT05342883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pilot Study of Resection and GammaTile Followed by Concomitant External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant in Newly Diagnosed Glioblastoma (GBM)
Study identification
- NCT ID
- NCT05342883
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- GT Medical Technologies, Inc.
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide) Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 16, 2022
- Primary completion
- Nov 30, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Sep 4, 2025
2022 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHeath Scottsdale Osborn Medical Center | Scottsdale | Arizona | 85251 | — |
| Keck Medicine of USC | Los Angeles | California | 90033 | — |
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | — |
| Advent Health Orlando | Orlando | Florida | 32803 | — |
| Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital | Tampa | Florida | 33606 | — |
| Piedmont Healthcare | Atlanta | Georgia | 30309 | — |
| RUSH University | Chicago | Illinois | 60607 | — |
| Indiana University Office of Clinical Research | Indianapolis | Indiana | 46202 | — |
| University of Kansas Hospital | Kansas City | Kansas | 66016 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| University of Minnesota | Minneapolis | Minnesota | 55485 | — |
| St. Louis University Hospital Center | St Louis | Missouri | 63110 | — |
| ECU Health Medical Center - Vidant | Greenville | North Carolina | 27834 | — |
| Kettering Medical Center | Kettering | Ohio | 45429 | — |
| Brown University Health | Providence | Rhode Island | 02906 | — |
| UTHealth Houston | Memorial Hermann Health System | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05342883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05342883 live on ClinicalTrials.gov.